ACRS

Aclaris Therapeutics Inc

• TipRanks·4d ago

  Aclaris Maintained at Buy as Analyst Sees Upside in ATI-052 Atopic Program, Keeps $13 Price Target Unchanged

• TipRanks·09/21 16:59

  3 High-Risk/High-Reward Stocks With 100%+ Upside Potential, According to Analysts

• NASDAQ·09/15 12:47

  Aclaris (ACRS) Soars 6.0%: Is Further Upside Left in the Stock?

• Benzinga·09/14 21:06

  12 Health Care Stocks Moving In Monday's After-Market Session

• TipRanks·09/05 09:01

  Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

• Dow Jones·09/01 17:55

  Aclaris Therapeutics Price Target Announced at $10.00/Share by Canaccord Genuity

• TipRanks·09/01 11:10

  Canaccord starts Aclaris with Buy on ‘sizeable’ U.S. opportunities

• TipRanks·09/01 10:25

  Aclaris Therapeutics initiated with a Buy at Canaccord

• Benzinga·08/25 12:02

  Vipshop, Gorilla Technology Group And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

• Benzinga·08/25 09:25

  Why Cadeler Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

• Seeking Alpha·08/10 12:49

  High-flyer healthcare stocks: Ten names with strong momentum, weak valuations

• Simply Wall St·08/07 22:27

  Aclaris Therapeutics (ACRS) Stock Drifts Lower As Losses Deepen On Thin Revenue

• TipRanks·08/07 15:27

  Aclaris Therapeutics (ACRS) Gets a Buy from Piper Sandler

• NASDAQ·08/07 05:20

  Aclaris Q2 Net Loss Expands; Secures FDA's Fast Track Designation For Modzatinib In Lichen Planus

• TipRanks·08/06 22:22

  Aclaris Updates At-The-Market Equity Sales Agreement